Regulating the Revolution: Ensuring Safe Innovation in Oncology Devices

IMT News Desk
IMT News Desk
· 5 min read

As oncology care turns to AI-driven imaging, robotic surgery, and targeted drug delivery, robust regulation becomes essential. Chandra Ganjoo, Group CEO, Trivitron Healthcare, explains how clear standards and transparent oversight can protect patients, foster trust, and drive the next wave of cancer-care advancements in India.

In paediatric, gynaecologic, radiation, surgical, or medical oncology, treatment, diagnosis, and follow-up of cancer patients must be carried out with the highest level of caution. In this context, the safety of the patient must be given top priority by the oncologists practicing. It is important to ensure that high-quality and high-performance medical devices are used. With controlled, patient-friendly medical equipment, cancer may be identified in the early stage and treated and monitored appropriately as well. Even the medical device regulation contributes greatly to embracing the future in Oncology. Here’s what we need to know!

Medical Device Regulation Importance In Oncology

  • Safety of the patient – Oncological practices are generally invasive and intricate. Hence, it is of utmost importance that medical imaging machines, surgical machines, and radiotherapy machines have reliability and precision to reduce hazards and complications.
  • Correct diagnosis – With right regulation of tissue analysis equipment, molecular testing kit, and biopsy needles, assured sound-based detection of cancer exists along with cancer staging, essential for developing patient-specific treatment programs.
  • Targeted treatment delivery – The medical devices utilized for target cancer treatment such as implantable Chemo ports and drug delivery systems, when regulated, provide accurate delivery of chemo-drugs to tumors without producing severe side effects.
  • Quality control – The regulation of medical devices provides standards for manufacturing processes, design, and performance testing. It ensures sustained excellent quality of medical devices and prevention of malfunctions in devices that may affect the patient’s diagnostic and therapeutic results.
  • Transparency and trust – The medical device manufacturers are required to reveal extensive information regarding their devices. So, with such transparency, there is establishment of trust with patients and oncologists about the devices’ safety and efficacy.
  • Innovation with accountability – While stimulating the progress of oncology technologies, the regulation also ensures that these innovative medical devices are comprehensively tested for safety and effectiveness prior to availability for use.

Medical devices in Oncology Impacted by Regulation

  • Imaging systems – Radiography, ultrasound, and MRI scans used in cancer diagnosis and monitoring require regulation to ensure that the quality and accuracy of images produced; only reliable and functioning equipment is employed in clinical practice; and radiation exposure is minimized, where applicable.
  • Radiation therapy devices – Radiation therapy equipment such as linear accelerator, teletherapy machine, brachytherapy machines, Gamma knife, robotic radiosurgery system, and TomoTherapy require regulation to administer adequate radiation doses and precision to targeted tumors without inflicting severe damage on adjacent healthy tissues.
  • Surgical devices – The laser, scalpel, and other surgical instruments employed in oncological surgery require regulation to prevent any malfunction when complicated cancer surgeries are performed.

Only reliable and functioning equipment is employed in clinical practice; and radiation exposure is minimised, where applicable.

The Future of Cancer Care with Regulated/Advanced Medical Devices

The latest innovations in oncologist-used medical devices that are currently in focus are:

  • Artificial intelligence (AI) – Data analysis by artificial intelligence enables the physician to determine the patient’s condition and design an appropriate treatment plan.
  • Digital therapeutics – Digital therapeutics is a feature of remote monitoring platforms that enable patients to obtain cancer treatment at home.
  • Robotic cancer surgery – Robot-assisted surgery is more accurate, less invasive, and enables faster healing. It is used for operating tumors in the initial stages of malignancy and tumors near sensitive organs.
  • Cancer vaccines – Certain cancers such as prostate cancer can be identified and destroyed using immuno-therapeutic vaccines.

Benefits offered by such innovations:

  • Enhancing survival for cancer patients – With advanced diagnostic and treatment modalities, oncologists are able to revolutionize the prognosis for cancer patients. Cancer patients are provided with a chance to enjoy a better quality of life.
  • Improved outcomes – With new medical devices, cancer can be diagnosed early, and better comprehended; the exact size, location, and molecular/genetic profile of the tumor can be known; and be successfully treated.
  • High-tailored treatments – The patients undergoing the treatment can be monitored real-time to understand how well the treatment is going. In case any problem arises, the diagnostic equipment can inform decisions on the best treatment.
  • Efficiency of the health system – Oncologists and cancer researchers opine that the widespread adoption of sophisticated cancer care can lead to a great deal of cost savings and decrease the burden of the workforce. There will be less utilization of treatments that prove to be ineffective for the patient, less necessity to deal with serious side effects, more automation of diagnostic equipment, and optimization of clinical workflows.

With advanced diagnostic and treatment modalities, oncologists are able to revolutionize the prognosis for cancer patients.

The Takeaway

Regulation of the medical device in oncology is very important because it guarantees patient safety, survival improvement, correct diagnosis, and better treatment. But the full implementation of innovative medical devices in a health system would require time. But the health systems must be ready for this. Policymakers need to learn from the problems driving disparities in access to innovative medical devices, so that these are not repeated or even worse in the future.

Read Next

Early Diagnosis, Preventive Treatment, Holistic Care: The Three Pillars of Living Better with Haemophilia
Featured Article
June 13, 2026

Early Diagnosis, Preventive Treatment, Holistic Care: The Three Pillars of Living Better with Haemophilia

Dr Vishnu Sharma, HOD of Haematology at SMS Medical College & Hospital, Jaipur, emphasizes the critical importance of early diagnosis and holistic care in managing haemophilia- a rare inherited bleeding disorder that affects an estimated 136,000 people in India, yet only 21,000-29,000 are formally registered. He explores how delayed diagnosis leads to preventable joint damage […]
Article by: Guest Author
Building Scalable, Safe Surgery in India: Why Robotic Platforms Need Systems, Not Just Technology
Opinion
June 2, 2026

Building Scalable, Safe Surgery in India: Why Robotic Platforms Need Systems, Not Just Technology

India stands at an inflection point in surgical care, where the pressure to meet rising demand is colliding with the imperative to keep surgery safe, predictable and patient-centric, writes Prof. (Dr.) Atul N. C. Peters, Principal Director, Dept. of Bariatric, Minimal Access and Robotic Surgery, Centre of Excellence, Max Smart Super Specialty Hospital, Saket, Delhi. […]
Article by: Guest Author
Why Women’s Health Needs More Attention in Healthcare
Featured Article
May 28, 2026

Why Women’s Health Needs More Attention in Healthcare

Women’s health is too often treated as secondary, delayed, or fragmented, even when the signs are clear. In this powerful piece, Anika Parashar, Founder & CEO of The Women’s Hospital, argues that women’s health is not a privilege or a favour, it is a fundamental right that demands dignity, access and lifelong care. I have […]
Article by: Sony Singh
The Hidden Cost of Bad Data in Hospitals: Where AI ROI Leaks First
Featured Article
May 26, 2026

The Hidden Cost of Bad Data in Hospitals: Where AI ROI Leaks First

Hospitals are investing heavily in AI to drive better outcomes and operational savings, but a pervasive and often overlooked threat is eroding those returns: poor data quality. Shradha Doshi, AVP of Provider and Healthcare Services at CitiusTech, explains how errors that originate at “Schegistration” (the scheduling–registration front end) ripple through clinical decision support, revenue cycle […]
Article by: Sony Singh